All In Biotech

Drug Trial Radar · NCT07115329

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Phase 2, Multicenter, Randomized, Double-Blind Evaluation of the Efficacy and Safety of Oral GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 164 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

164

Planned (sponsor's estimate)

Start

Jan 5, 2026

Primary completion

Mar 30, 2028

Study completion Jun 2028

Sponsor

Lead sponsor
Syndeio Biosciences, IncIndustry
Sponsor type
Industry
Collaborators
Worldwide Clinical Trials
First posted
Aug 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does zelquistinel reduce depression scores in participants compared to participants who take a placebo (a look-alike tablet that contains no zelquistinel1)? What medical problems are observed in participants who take zelquistinel? Participants will take one tablet of zelquistinel or placebo every week for 6 weeks. Participants will visit the clinic every week of the 6 week period to have the severity of their depression evaluated.

Conditions

  • Major Depressive Disorder

Interventions

  • ZelquistinelDrug

    Zelquistinel is a positive allosteric modulator of the N-Methyl-D-Aspartate (NMDA) receptor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in the Hamilton Depression Rating Scale-17 (HDRS-17) score compared to PlaceboTime frame: Change in score from baseline to 6 wweeks

Locations

32 sites in 1 country. Site status is shown where the registry gives one.

  • NoesisPharma, LLC

    Phoenix, Arizona · Recruiting

  • Del Sol Research Management

    Tucson, Arizona · Recruiting

  • Catalina Research Institute, LLC

    Montclair, California · Recruiting

  • Excell Research, Inc

    Oceanside, California · Recruiting

  • Anderson Clinical Research

    Redlands, California · Recruiting

  • Studyops Inc

    San Francisco, California · Recruiting

  • Lumos Clinical Research Center

    San Jose, California · Recruiting

  • Sunwise Clinical Research

    Walnut Creek, California · Not yet recruiting

  • Clinical Neuroscience Solutions, Inc

    Jacksonville, Florida · Not yet recruiting

  • Premier Clinical Research Institute Inc

    Miami, Florida · Not yet recruiting

  • Aqualane Clinical Research

    Naples, Florida · Recruiting

  • EquiPath Health and Research Tampa Bay, LLC

    Riverview, Florida · Recruiting

  • Neuroscience Research Institute

    West Palm Beach, Florida · Recruiting

  • Denali Health Atlanta, LLC

    Stone Mountain, Georgia · Recruiting

  • EmVenio Research

    Chicago, Illinois · Recruiting

  • Tandem Clinical Research

    Metairie, Louisiana · Recruiting

  • Sunstone Therapies

    Rockville, Maryland · Withdrawn

  • Continental Clinical Solutions

    Towson, Maryland · Recruiting

  • Vitalix Clinical

    Worcester, Massachusetts · Recruiting

  • Rochester Center for Behavioral Medicine

    Rochester Hills, Michigan · Recruiting

  • Neurobehavioral Research, Inc

    Cedarhurst, New York · Not yet recruiting

  • IMA Clinical Research - NYC Midtown

    New York, New York · Recruiting

  • IMA Clinical Research - NYC Uptown

    New York, New York · Recruiting

  • UNC Health Rex

    Raleigh, North Carolina · Recruiting

  • Insight Clinical Trials LLC

    Independence, Ohio · Not yet recruiting

  • Lehigh Center for Clinical Research

    Allentown, Pennsylvania · Not yet recruiting

  • Scranton Medical Institute, LLC

    Moosic, Pennsylvania · Terminated

  • Adams Clinical

    Philadelphia, Pennsylvania · Recruiting

  • Psychiatric Consultants, PC

    Franklin, Tennessee · Recruiting

  • Elevate Synapsis, LLC

    Atascocita, Texas · Recruiting

  • Synapsis Bio

    Atascocita, Texas · Recruiting

  • Adams Clinical Dallas

    DeSoto, Texas · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.